Search EdNeuro Page
Search EdNeuro Page
The search found 219 results in 0.034 seconds.
Three collaborative pilot project grants have been awarded to foster trans-Atlantic cooperation
Dr Carole Torsney (Centre for Discovery Brain Sciences), Dr Lesley Colvin (Critical Care and Pain Medicine) and colleagues at the Univeristy of Aberdeen have published a study indicating that melatonin (often used to treat jet lag) may help reduce the neuropathic pain that is experienced by almost 70% of patients undergoing chemotherapy treatment for cancer.
Our 2016 Christmas Lecture by Professor Richard Morris (Professor of Neuroscience, Centre for Cognitive & Neural Systems, and 2016 Brain Prize Winner) on 'Memory: why it matters and how it works' is now available to view on our Edinburgh Neuroscience YouTube channel. Please feel free to share with family and friends!
Prof Andrew McIntosh (Centre for Clinical Brain Sciences - Psychiatry and Centre for Cognitive Ageing & Cognitive Epidemiology) has been awarded a prestigious Medical Research Council Data Pathfinder Award to create secure facilities for health data research, which will form a vital resource for Scottish researchers working to understand mental health conditions such as depression.
The Centre for Cognitive Ageing & Cognitive Epidmiology have found that people in their 40s and 50s who were more engaged with hobbies scored better on memory and thinking tests as they approached 80.
Professor Sharon Abrahams (Psychology and Euan MAcDoanld Centre for MND Research) has found thatfour out of five people with motor neuron disease are likely to experience changes in their brain function, as well as impaired movement.
Professor Tom GIllingwater (Centre for Integrative Physiology, and Euan MacDonald Centre for MND Research) has been awarded a grant from MND (Motor Neurone Disease) Scotland for the project titled: 'Identifying and targeting neuroprotective pathways in motor neurons'. Congratulations Tom!
Researchers at the University of Edinburgh (Dr Barry McColl, Laura McCulloch and colleagues - Roslin Institute) have been awarded a £1.3M grant from the Medical Research Council (MRC) to study the immunological mechanisms related to B cell function that are disrupted after stroke and could contribute to stroke-associated infection (SAI).
The groundbreaking MS-STAT2 trial led by Dr Peter Connick, Anne Rowling Regenerative Neurology Clinic, was recently featured in the Scotsman. It is the largest ever trial for secondary progressive multiple sclerosis and aims to confirm whether the drug simvastatin could become one of the first drugs to slow or stop the disability’s progression – offering hope to thousands of people living with the condition.
Congratulations to Dr Patrick Kearns (Centre for Clinical Brain Sciences) and colleagues who have published a study in The Journal of Neurology, providing the first detailed snapshot of people affected by multiple sclerosis across Scotland.